Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
about
Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.Glucose metabolism disorders and the risk of cancer.Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.Association between Components of the Insulin-Like Growth Factor System and Epithelial Ovarian Cancer RiskAssociation between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
P2860
Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@en
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@nl
type
label
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@en
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@nl
prefLabel
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@en
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@nl
P2093
P50
P921
P356
P1476
Risk of ovarian cancer in rela ...... 1 and -2 (USA, Sweden, Italy).
@en
P2093
Arslan Akhmedkhanov
Carine Biessy
Franco Berrino
Paola Muti
Paolo Toniolo
P2888
P304
P356
10.1023/A:1023688603547
P50
P577
2003-04-01T00:00:00Z
P6179
1022775697